688581 安杰思
已收盘 06-03 15:00:00
资讯
新帖
简况
每周股票复盘：安杰思（688581）变更持续督导保荐代表人
证券之星 · 05-31
每周股票复盘：安杰思（688581）变更持续督导保荐代表人
安杰思（688581）披露关于变更保荐代表人的公告，5月29日股价下跌1.98%
证券之星 · 05-29
安杰思（688581）披露关于变更保荐代表人的公告，5月29日股价下跌1.98%
每周股票复盘：安杰思（688581）终止员工持股计划并减资
证券之星 · 05-17
每周股票复盘：安杰思（688581）终止员工持股计划并减资
安杰思（688581）披露注销2025年员工持股计划全部股票并减少注册资本暨通知债权人公告，5月15日股价下跌2.7%
证券之星 · 05-15
安杰思（688581）披露注销2025年员工持股计划全部股票并减少注册资本暨通知债权人公告，5月15日股价下跌2.7%
安杰思涨8.89%，开源证券二周前给出“买入”评级
证券之星 · 05-13
安杰思涨8.89%，开源证券二周前给出“买入”评级
每周股票复盘：安杰思（688581）2025年年度股东会审议多项议案
证券之星 · 05-10
每周股票复盘：安杰思（688581）2025年年度股东会审议多项议案
安杰思（688581）披露2025年年度股东会会议资料，5月7日股价下跌0.12%
证券之星 · 05-07
安杰思（688581）披露2025年年度股东会会议资料，5月7日股价下跌0.12%
安杰思涨5.55%，开源证券二日前给出“买入”评级
证券之星 · 04-28
安杰思涨5.55%，开源证券二日前给出“买入”评级
安杰思（688581）2026年一季报简析：营收净利润同比双双增长，三费占比上升明显
证券之星 · 04-24
安杰思（688581）2026年一季报简析：营收净利润同比双双增长，三费占比上升明显
安杰思（688581）披露2026年第一季度报告，4月23日股价上涨3.56%
证券之星 · 04-23
安杰思（688581）披露2026年第一季度报告，4月23日股价上涨3.56%
图解安杰思年报：第四季度单季净利润同比下降53.40%
证券之星 · 04-23
图解安杰思年报：第四季度单季净利润同比下降53.40%
每周股票复盘：安杰思（688581）股东新建元拟减持不超2%
证券之星 · 03-22
每周股票复盘：安杰思（688581）股东新建元拟减持不超2%
安杰思最新公告：股东新建元拟减持不超2.00%公司股份
证券之星 · 03-19
安杰思最新公告：股东新建元拟减持不超2.00%公司股份
安杰思（688581）披露为控股子公司提供担保进展公告，3月13日股价上涨0.1%
证券之星 · 03-13
安杰思（688581）披露为控股子公司提供担保进展公告，3月13日股价上涨0.1%
每周股票复盘：安杰思（688581）股东户数较上期减少28.0户
证券之星 · 03-08
每周股票复盘：安杰思（688581）股东户数较上期减少28.0户
安杰思公布国际专利申请：“手术器具及应用于内窥镜的辅助装置”
证券之星 · 03-07
安杰思公布国际专利申请：“手术器具及应用于内窥镜的辅助装置”
安杰思(688581)2月27日股东户数0.63万户，较上期减少0.44%
证券之星 · 03-02
安杰思(688581)2月27日股东户数0.63万户，较上期减少0.44%
每周股票复盘：安杰思（688581）2025年净利润下降24.06%
证券之星 · 03-01
每周股票复盘：安杰思（688581）2025年净利润下降24.06%
安杰思发布2025年度业绩快报，盈利2.228亿元
证券之星 · 02-26
安杰思发布2025年度业绩快报，盈利2.228亿元
安杰思(688581)2月10日股东户数0.63万户，较上期增加0.43%
证券之星 · 02-12
安杰思(688581)2月10日股东户数0.63万户，较上期增加0.43%
暂无数据
公司概况
公司名称：
杭州安杰思医学科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2023-05-19
主营业务：
杭州安杰思医学科技股份有限公司的主营业务是内镜微创诊疗器械的研发、生产与销售。公司的主要产品是GI类、EMR/ESD类、ERCP类、仪器类。
发行价格：
125.80
{"stockData":{"symbol":"688581","market":"SH","secType":"STK","nameCN":"安杰思","latestPrice":54.89,"timestamp":1780470000000,"preClose":55.34,"halted":0,"volume":484018,"delay":0,"changeRate":-0.0081,"floatShares":41559700,"shares":81122100,"eps":2.7399,"marketStatus":"已收盘","change":-0.45,"latestTime":"06-03 15:00:00","open":55.07,"high":55.56,"low":54,"amount":26513600,"amplitude":0.0282,"askPrice":54.89,"askSize":2,"bidPrice":54.65,"bidSize":3,"shortable":0,"etf":0,"ttmEps":2.7399,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1780536600000},"marketStatusCode":5,"adr":0,"adjPreClose":55.34,"symbolType":"stock_kcb","openAndCloseTimeList":[[1780450200000,1780457400000],[1780462800000,1780470000000]],"highLimit":60.87,"lowLimit":49.81,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":81122079,"isCdr":false,"pbRate":1.73,"roa":"--","peRate":20.033578,"roe":"2.23%","epsLYR":2.76,"committee":-0.401869,"marketValue":4453000000,"turnoverRate":0.0116,"status":1,"afterMarket":{"amount":0,"volume":0,"close":54.89,"buyVolume":0,"sellVolume":500,"time":1780472038866,"indexStatus":"已收盘 06-03 15:30:00","preClose":55.34},"floatMarketCap":2281000000},"requestUrl":"/m/hq/s/688581/tweets","defaultTab":"tweets","newsList":[{"id":"2639046786","title":"每周股票复盘：安杰思（688581）变更持续督导保荐代表人","url":"https://stock-news.laohu8.com/highlight/detail?id=2639046786","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639046786?lang=zh_cn&edition=full","pubTime":"2026-05-31 03:14","pubTimestamp":1780168452,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，安杰思报收于55.99元，较上周的61.86元下跌9.49%。变更后，公司持续督导保荐代表人为杨波先生和余启东先生，持续督导期至2026年12月31日。本次变更不影响此前保荐机构及保荐代表人所出具文件的真实性和准确性，相关责任仍由其承担。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100000902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639673711","title":"安杰思（688581）披露关于变更保荐代表人的公告，5月29日股价下跌1.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2639673711","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639673711?lang=zh_cn&edition=full","pubTime":"2026-05-29 22:26","pubTimestamp":1780064779,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，安杰思报收于55.99元，较前一交易日下跌1.98%，最新总市值为45.42亿元。该股当日开盘57.12元，最高57.3元，最低55.6元，成交额达3799.07万元，换手率为1.63%。近日，杭州安杰思医学科技股份有限公司收到中信证券关于更换持续督导保荐代表人的函，原保荐代表人徐峰先生因工作安排不再负责公司持续督导工作，中信证券委派杨波先生接替其职务。本次变更不影响此前保荐机构及保荐代表人所出具文件的真实性和准确性，相关责任仍由其承担。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900046374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636705064","title":"每周股票复盘：安杰思（688581）终止员工持股计划并减资","url":"https://stock-news.laohu8.com/highlight/detail?id=2636705064","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636705064?lang=zh_cn&edition=full","pubTime":"2026-05-17 03:52","pubTimestamp":1778961132,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，安杰思报收于62.62元，较上周的63.38元下跌1.2%。本周关注点公司公告汇总：安杰思终止2025年员工持股计划并注销381,423股股票，注册资本将由81,122,079元减少至80,740,656元。安杰思关于注销2025年员工持股计划全部股票并减少注册资本暨通知债权人的公告杭州安杰思医学科技股份有限公司于2026年4月21日和5月15日分别召开董事会及年度股东大会，审议通过终止实施2025年员工持股计划并回购注销全部股票的议案。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001215.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635603306","title":"安杰思（688581）披露注销2025年员工持股计划全部股票并减少注册资本暨通知债权人公告，5月15日股价下跌2.7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635603306","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635603306?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:46","pubTimestamp":1778856376,"startTime":"0","endTime":"0","summary":"近日，杭州安杰思医学科技股份有限公司披露《关于注销2025年员工持股计划全部股票并减少注册资本暨通知债权人的公告》。公告显示，公司于2026年4月21日和5月15日分别召开董事会及年度股东大会，审议通过终止实施2025年员工持股计划并回购注销全部股票的议案。公司将注销已终止员工持股计划涉及的381,423股股票，注册资本由81,122,079元减少至80,740,656元，股本总额由81,122,079股减少至80,740,656股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500044419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635201789","title":"安杰思涨8.89%，开源证券二周前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2635201789","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635201789?lang=zh_cn&edition=full","pubTime":"2026-05-13 16:32","pubTimestamp":1778661163,"startTime":"0","endTime":"0","summary":"今日安杰思涨8.89%，收盘报69.8元。2026年4月26日，开源证券研究员余汝意,陈峻,石启正发布了对安杰思的研报《公司信息更新报告：持续布局前沿技术方向，26年有望困境反转》，该研报对安杰思给出“买入”评级。考虑到公司海外业务的稳定放量，海外业务有望进一步增长，我们维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为华金证券的周平。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051300029541.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634209414","title":"每周股票复盘：安杰思（688581）2025年年度股东会审议多项议案","url":"https://stock-news.laohu8.com/highlight/detail?id=2634209414","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634209414?lang=zh_cn&edition=full","pubTime":"2026-05-10 02:53","pubTimestamp":1778352788,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘，安杰思报收于63.38元，较上周的60.6元上涨4.59%。本周，安杰思5月8日盘中最高价报63.66元。本周关注点公司公告汇总：安杰思2025年年度股东会将审议包括年度报告、利润分配预案、续聘会计师事务所等12项议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001077.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633011297","title":"安杰思（688581）披露2025年年度股东会会议资料，5月7日股价下跌0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633011297","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633011297?lang=zh_cn&edition=full","pubTime":"2026-05-07 17:59","pubTimestamp":1778147964,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，安杰思报收于60.3元，较前一交易日下跌0.12%，最新总市值为48.92亿元。该股当日开盘60.3元，最高61.16元，最低59.7元，成交额达5562.17万元，换手率为2.22%。公司于近日披露《安杰思2025年年度股东会会议资料》。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700030492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630137577","title":"安杰思涨5.55%，开源证券二日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2630137577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630137577?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:27","pubTimestamp":1777364854,"startTime":"0","endTime":"0","summary":"今日安杰思涨5.55%，收盘报61.8元。2026年4月26日，开源证券研究员余汝意,陈峻,石启正发布了对安杰思的研报《公司信息更新报告：持续布局前沿技术方向，26年有望困境反转》，该研报对安杰思给出“买入”评级。考虑到公司海外业务的稳定放量，海外业务有望进一步增长，我们维持“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为华金证券的周平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800049106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629840136","title":"安杰思（688581）2026年一季报简析：营收净利润同比双双增长，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2629840136","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629840136?lang=zh_cn&edition=full","pubTime":"2026-04-24 22:28","pubTimestamp":1777040905,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期安杰思发布2026年一季报。截至本报告期末，公司营业总收入1.4亿元，同比上升9.21%，归母净利润5679.62万元，同比上升0.97%。本报告期安杰思三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达30.7%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400065147.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629882453","title":"安杰思（688581）披露2026年第一季度报告，4月23日股价上涨3.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629882453","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629882453?lang=zh_cn&edition=full","pubTime":"2026-04-23 17:55","pubTimestamp":1776938151,"startTime":"0","endTime":"0","summary":"截至2026年4月23日收盘，安杰思报收于58.16元，较前一交易日上涨3.56%，最新总市值为47.18亿元。该股当日开盘56.86元，最高58.5元，最低56.86元，成交额达7020.13万元，换手率为2.91%。公司于近日披露《2026年第一季度报告》。报告显示，2026年第一季度营业收入为140,441,869.50元，同比增长9.21%；归属于上市公司股东的净利润为56,796,176.00元，同比增长0.97%；经营活动产生的现金流量净额为58,166,364.38元，同比大幅增长672.30%。研发投入合计15,648,726.26元，占营业收入比例为11.14%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300049526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629021301","title":"图解安杰思年报：第四季度单季净利润同比下降53.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629021301","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629021301?lang=zh_cn&edition=full","pubTime":"2026-04-23 01:40","pubTimestamp":1776879620,"startTime":"0","endTime":"0","summary":"证券之星消息，安杰思2025年年报显示，当年度公司主营收入5.94亿元，同比下降6.74%；归母净利润2.22亿元，同比下降24.43%；扣非净利润1.9亿元，同比下降30.4%；其中2025年第四季度，公司单季度主营收入1.34亿元，同比下降35.8%；单季度归母净利润4470.39万元，同比下降53.4%；单季度扣非净利润4021.54万元，同比下降50.43%；负债率5.99%，投资收益3697.08万元，财务费用-233.03万元，毛利率71.09%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042300003281.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621179992","title":"每周股票复盘：安杰思（688581）股东新建元拟减持不超2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2621179992","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621179992?lang=zh_cn&edition=full","pubTime":"2026-03-22 03:02","pubTimestamp":1774119734,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，安杰思报收于55.08元，较上周的58.14元下跌5.26%。本周，安杰思3月17日盘中最高价报58.65元。本周关注点公司公告汇总：股东新建元因自身经营需要，计划减持不超2%股份公司公告汇总安杰思股东新建元持有公司3.5601%股份，计划减持不超过1,622,440股，即不超过公司总股本的2.0000%，其中通过集中竞价和大宗交易方式各减持不超过811,220股。股东承诺将遵守相关减持规定并履行信息披露义务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620240389","title":"安杰思最新公告：股东新建元拟减持不超2.00%公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2620240389","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620240389?lang=zh_cn&edition=full","pubTime":"2026-03-19 20:00","pubTimestamp":1773921610,"startTime":"0","endTime":"0","summary":"安杰思(688581.SH)公告称，股东苏州工业园区新建元二期创业投资企业(有限合伙)因自身经营需要，拟合计减持不超过162.24万股公司股份，占公司总股本的2.0000%。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031900034375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619116841","title":"安杰思（688581）披露为控股子公司提供担保进展公告，3月13日股价上涨0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619116841","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619116841?lang=zh_cn&edition=full","pubTime":"2026-03-13 22:54","pubTimestamp":1773413656,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，安杰思报收于58.14元，较前一交易日上涨0.1%，最新总市值为47.16亿元。近日，安杰思发布《关于为控股子公司提供担保的进展公告》。公告显示，杭州安杰思医学科技股份有限公司为控股子公司杭安医学科技（杭州）有限公司向中信银行申请授信提供2,000万元最高额连带责任担保。杭安医学为公司持股95.8333%的控股子公司，截至公告日，公司为其实际担保余额为2,000万元，无逾期担保。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031300042044.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617638306","title":"每周股票复盘：安杰思（688581）股东户数较上期减少28.0户","url":"https://stock-news.laohu8.com/highlight/detail?id=2617638306","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617638306?lang=zh_cn&edition=full","pubTime":"2026-03-08 02:46","pubTimestamp":1772909171,"startTime":"0","endTime":"0","summary":"截至2026年3月6日收盘，安杰思报收于58.12元，较上周的60.09元下跌3.28%。本周，安杰思3月2日盘中最高价报59.68元。3月4日盘中最低价报57.31元。安杰思当前最新总市值47.15亿元，在医疗器械板块市值排名77/129，在两市A股市值排名3682/5190。本周关注点股本股东变化：股东户数较上期减少28.0户股本股东变化：户均持股市值为77.22万元股本股东变化股东户数变动截至2026年2月27日，公司股东户数为6313.0户，较2月10日减少28.0户，减幅为0.44%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030800000901.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617653532","title":"安杰思公布国际专利申请：“手术器具及应用于内窥镜的辅助装置”","url":"https://stock-news.laohu8.com/highlight/detail?id=2617653532","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617653532?lang=zh_cn&edition=full","pubTime":"2026-03-07 05:44","pubTimestamp":1772833466,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示安杰思（688581）公布了一项国际专利申请，专利名为“手术器具及应用于内窥镜的辅助装置”，专利申请号为PCT/CN2025/117377，国际公布日为2026年3月5日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来安杰思已公布的国际专利申请2个，较去年同期增加了100%。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了3445.78万元，同比增33.29%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030700002591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616838765","title":"安杰思(688581)2月27日股东户数0.63万户，较上期减少0.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616838765","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616838765?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:26","pubTimestamp":1772443601,"startTime":"0","endTime":"0","summary":"证券之星消息，近日安杰思披露，截至2026年2月27日公司股东户数为6313.0户，较2月10日减少28.0户，减幅为0.44%。在医疗器械行业个股中，安杰思股东户数低于行业平均水平，截至2月27日，医疗器械行业平均股东户数为2.22万户。从股价来看，2026年2月10日至2026年2月27日，安杰思区间跌幅为2.02%，在此期间股东户数减少28.0户，减幅为0.44%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200025220.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616843584","title":"每周股票复盘：安杰思（688581）2025年净利润下降24.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616843584","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616843584?lang=zh_cn&edition=full","pubTime":"2026-03-01 01:55","pubTimestamp":1772301313,"startTime":"0","endTime":"0","summary":"截至2026年2月27日收盘，安杰思报收于60.09元，较上周的60.7元下跌1.0%。本周，安杰思2月26日盘中最高价报61.58元。本周关注点来自业绩披露要点：安杰思2025年归属净利润同比下降24.06%，达2.228亿元。公司公告汇总杭州安杰思医学科技股份有限公司于2023年5月完成首次公开发行，募集资金净额165,101.28万元。为实施安杰思泰国生产基地项目，公司使用部分结余募集资金约14,500万元及部分超募资金4,000万元进行投资。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100000517.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614042614","title":"安杰思发布2025年度业绩快报，盈利2.228亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614042614","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2614042614?lang=zh_cn&edition=full","pubTime":"2026-02-26 21:20","pubTimestamp":1772112034,"startTime":"0","endTime":"0","summary":"证券之星消息，安杰思近日即将发布2025年年报，根据2月26日发布的业绩快报，归属净利润盈利2.228亿元，同比减少24.06%。安杰思（688581）主营业务：内镜微创诊疗器械的研发、生产与销售。该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026022600036547.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610494628","title":"安杰思(688581)2月10日股东户数0.63万户，较上期增加0.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2610494628","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610494628?lang=zh_cn&edition=full","pubTime":"2026-02-12 17:28","pubTimestamp":1770888500,"startTime":"0","endTime":"0","summary":"证券之星消息，近日安杰思披露，截至2026年2月10日公司股东户数为6341.0户，较1月30日增加27.0户，增幅为0.43%。在医疗器械行业个股中，安杰思股东户数低于行业平均水平，截至2月10日，医疗器械行业平均股东户数为2.21万户。从股价来看，2026年1月30日至2026年2月10日，安杰思区间涨幅为0.03%，在此期间股东户数增加27.0户，增幅为0.43%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021200028273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688581"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1780483039675,"stockEarnings":[{"period":"1week","weight":-0.0746},{"period":"1month","weight":-0.0868},{"period":"3month","weight":-0.0362},{"period":"6month","weight":-0.056},{"period":"1year","weight":-0.1177},{"period":"ytd","weight":-0.0561}],"compareEarnings":[{"period":"1week","weight":-0.017},{"period":"1month","weight":-0.009},{"period":"3month","weight":-0.0018},{"period":"6month","weight":0.0514},{"period":"1year","weight":0.2174},{"period":"ytd","weight":0.0268}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州安杰思医学科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"6191人(较上一季度减少1.93%)","perCapita":"6712股","listingDate":"2023-05-19","address":"浙江省杭州市临平区兴中路389号","registeredCapital":"8112万元","survey":" 杭州安杰思医学科技股份有限公司的主营业务是内镜微创诊疗器械的研发、生产与销售。公司的主要产品是GI类、EMR/ESD类、ERCP类、仪器类。","listedPrice":125.8},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安杰思(688581)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安杰思(688581)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安杰思,688581,安杰思股票,安杰思股票老虎,安杰思股票老虎国际,安杰思行情,安杰思股票行情,安杰思股价,安杰思股市,安杰思股票价格,安杰思股票交易,安杰思股票购买,安杰思股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安杰思(688581)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安杰思(688581)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}